Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome.
about
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian PopulationObesity in cancer survivalRelationships between inflammation, adiponectin, and oxidative stress in metabolic syndromeThe metabolic syndromeMetabolic syndrome and inflammatory biomarkers in adults: a population-based survey in Western region of iran.Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome.GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome.The effects of exercise modalities on adiposity in obese rats.Grape consumption increases anti-inflammatory markers and upregulates peripheral nitric oxide synthase in the absence of dyslipidemias in men with metabolic syndromeMetabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study.IMMUNOLOGICAL EVALUATION OF PATIENTS WITH TYPE 2 DIABETES MELLITUS SUBMITTED TO METABOLIC SURGERYVitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral TherapyAdiponectin as an anti-inflammatory factor.Cardiovascular changes in animal models of metabolic syndromeReduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional studyLongitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey.Comparative insights into the regulation of inflammation: levels and predictors of interleukin 6 and interleukin 10 in young adults in the Philippines.Obesity, insulin resistance, and cancer prognosis: implications for practice for providing care among cancer survivors.Obesity, inflammation, and liver cancer.Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.Dyslipidemia rather than Type 2 Diabetes Mellitus or Chronic Periodontitis Affects the Systemic Expression of Pro- and Anti-Inflammatory Genes.The relationship between metabolic syndrome (MetS) and spontaneous intracerebral hemorrhage (ICH).Treatment and outcomes in diabetic breast cancer patients.Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity.Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study.Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.Inflammatory Biomarkers of Cardiometabolic Risk in Obese Egyptian Type 2 Diabetics.A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors.Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients.Association of IL-10 gene (-1082A>G, -819C>T and -592C>A) polymorphism and its serum level with metabolic syndrome of north Indian subjects.Effects of periodontal treatment on inflammation and oxidative stress markers in patients with metabolic syndrome.Adiponectin Signaling Pathways in Liver Diseases.Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men
P2860
Q26774109-15759804-8862-4131-A223-8A9CF80EDEE0Q26863606-1FC492A2-56A1-4F8B-B237-C4D4BD909ED2Q28483891-285F07D0-6CDD-4C7C-83AE-DA3C12AD7BC5Q33569142-CF4206C5-F292-4E16-8CDA-3C3CA679F2A4Q34997805-FF2C60B5-FB0C-4D48-9164-80E4E4F8E6F2Q35686289-339D168C-53E5-4E83-9818-AF3F8C2E1A60Q36227874-C12A651B-D506-4A2A-BEA4-A35D41D5B87AQ36465373-3B2B895A-B21F-4F54-A73E-FB514C4CBBACQ36538131-79DE8626-09F4-40AB-A9F7-DB9FC77FCE97Q36541754-6E192F4C-0877-43FC-BCA3-6639EB554188Q36584492-4CA72EFB-7BE7-4760-980F-32056A86D6AFQ36656763-C6DBE278-13B2-4486-A7D9-1757D97F579FQ36753830-E8592C93-170C-49C7-B8AE-49D79AB070EBQ36825744-4FFB2094-28AD-4333-AFB8-2F7A5712D1CDQ37212046-408FE3C5-0000-4282-B3A4-2D18A293D834Q37279091-F8236862-32ED-46F0-AD9A-7A9CC569CDC1Q37338671-BFB789B3-B02C-4316-827C-FCB112246EF6Q37379329-FE6B5042-22C0-48C3-AA22-7348580CD078Q37469981-C90263D9-8E0D-43A4-900C-A4A4E7CF4CE7Q37494299-E295AB38-CBEC-4E05-8D81-437F913B3144Q37681581-3CFCC22F-6B6F-412F-9EBE-1D2EE8054F09Q38069499-16C7B780-6FA3-4EE1-B950-EFE90BEDF04FQ38180008-613E20F6-D991-430D-9AE9-24FF7A3B99D1Q43472253-D341AA01-D52A-414A-A556-F46F3C7058ABQ43727420-F6174D62-EF60-4CD2-B259-D1B761D8EBB9Q45966946-A9C400DE-281A-4221-B4BF-B557D15D4E3DQ46452148-1AE1BD6E-E69A-4543-BFB1-4301050DA5C6Q47445962-E94ABD9F-AD66-44B2-BC4D-46E7C19DA5BCQ47680814-2CBE70E1-B999-4FAF-8EBB-7AA0528B33BAQ47743748-14A95104-0E29-4F7B-9993-04E3B2D29644Q51080285-0145569A-66D5-4C52-BF75-A64C33C04A9DQ51294392-45D94436-1E9F-4C6E-8C89-D05EA9104FE2Q55619181-F0BA771B-0AB8-458A-9FAE-0E4DBC449DE0Q57416312-7FF57403-47A3-4815-BBCA-55765C49B94B
P2860
Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Serum adiponectin, interleukin ...... ers in the metabolic syndrome.
@en
Serum adiponectin, interleukin ...... ers in the metabolic syndrome.
@nl
type
label
Serum adiponectin, interleukin ...... ers in the metabolic syndrome.
@en
Serum adiponectin, interleukin ...... ers in the metabolic syndrome.
@nl
prefLabel
Serum adiponectin, interleukin ...... ers in the metabolic syndrome.
@en
Serum adiponectin, interleukin ...... ers in the metabolic syndrome.
@nl
P2093
P921
P1476
Serum adiponectin, interleukin ...... ers in the metabolic syndrome.
@en
P2093
P304
P356
10.1016/J.DIABRES.2006.06.019
P577
2006-07-26T00:00:00Z